Oral Cavity and Oropharyngeal Cancer Stages
After someone is diagnosed with oral cavity or oropharyngeal cancer, doctors will try to figure out if it has spread, and if so, how far. This process is called staging. The stage of a cancer describes how much cancer is in the body. It helps determine how serious the cancer is and how best to treat it. Doctors also use a cancer's stage when talking about survival statistics.
The earliest stage oral cavity or oropharyngeal cancers are called stage 0 (carcinoma in situ). Stages then range from I (1) through IV (4). As a rule, the lower the number, the less the cancer has spread. A higher number, such as stage IV, means cancer has spread more. And within a stage, an earlier letter means a lower stage. Although each person’s cancer experience is unique, cancers with similar stages tend to have a similar outlook and are often treated in much the same way.
How is the stage determined?
The staging system most often used for oral cavity or oropharyngeal cancers is the American Joint Committee on Cancer (AJCC) TNM system, which is based on 3 key pieces of information:
- The extent of the tumor (T): How large is the main (primary) tumor and which, if any, tissues of the oral cavity or oropharynx it has spread to?
- The spread to nearby lymph nodes (N): Has the cancer spread to nearby lymph nodes? If so, how many , are they on the same side where the cancer started, and how large are they?
- The spread (metastasis) to distant sites (M): Has the cancer spread to distant organs such as the lungs?
Numbers or letters after T, N, and M provide more details about each of these factors. Higher numbers mean the cancer is more advanced. Once a person’s T, N, and M categories have been determined, this information is combined in a process called stage grouping to assign an overall stage. For more information see Cancer Staging.
The staging system in the table below is based on the most recent AJCC system, effective January 2018. It uses the pathologic stage (also called the surgical stage). It's determined by examining the tissue removed during an operation. Sometimes, if surgery isn't possible right away or at all, the cancer will be given a clinical stage instead (which is not shown below). This is based on the results of a physical exam, endoscopy exam, biopsy, and imaging tests. The clinical stage will be used to help plan treatment. Sometimes, though, the cancer has spread further than the clinical stage estimates, and it may not predict the patient’s outlook as accurately as a pathologic stage.
Oropharyngeal cancers that contain HPV DNA (called p16-positive) tend to have a better outlook than those without HPV (p16-negative). Because p16-positive cancers have a better prognosis than p16-negative oropharyngeal cancers, separate staging systems are used. Both systems are described below.
Cancer staging can be complex, so ask your doctor to explain it to you in a way you understand. Explore the 3D interactive model here to learn more.
Lip, oral cavity, and p16 (HPV)-negative oropharynx cancer stages
AJCC stage |
Stage grouping |
Lip, oral cavity and p16 (HPV)-negative oropharynx cancer stage description* (2 cm = about ¾ inch; 3 cm = about 1¼ ; 4 cm = about 1½) |
0 |
Tis N0 M0 |
The cancer is still within the epithelium (the top layer of cells lining the oral cavity and oropharynx) and has not yet grown into deeper layers. It has not spread to nearby lymph nodes (N0) or distant sites (M0). This stage is also known as carcinoma in situ (Tis). |
I |
T1 N0 M0 |
The cancer is 2 cm or smaller. It’s not growing into nearby tissues (T1). It has not spread to nearby lymph nodes (N0) or to distant sites (M0). |
II |
T2 N0 M0 |
The cancer is larger than 2 cm but no larger than 4 cm . It’s not growing into nearby tissues (T2). It has not spread to nearby lymph nodes (N0) or to distant sites (M0). |
III
|
T3 N0 M0 |
The cancer is larger than 4 cm (T3). For cancers of the oropharynx, T3 also includes tumors that are growing into the epiglottis (the base of the tongue). It has not spread to nearby lymph nodes (N0) or to distant sites (M0). |
OR |
||
T1, T2, T3 N1 M0 |
The cancer is any size and may have grown into nearby structures if oropharynx cancer(T1-T3) AND has spread to 1 lymph node on the same side as the primary tumor. The cancer has not grown outside of the lymph node and the lymph node is no larger than 3 cm (N1). It has not spread to distant sites (M0). |
|
IVA |
T4a N0 or N1 M0 |
The cancer is any size and is growing into nearby structures such as:
This is known as moderately advanced local disease (T4a). AND either of the following:
It has not spread to distant sites (M0). |
OR |
||
T1, T2, T3 or T4a N2 M0 |
The cancer is any size and may have grown into nearby structures (T0-T4a). It has not spread to distant organs (M0). It has spread to one of the following:
|
|
IVB |
Any T N3 M0 |
The cancer is any size and may have grown into nearby soft tissues or structures (Any T) AND any of the following:
It has not spread to distant organs (M0). |
OR |
||
T4b Any N M0 |
The cancer is any size and is growing into nearby structures such as the base of the skull or other bones nearby, or it surrounds the carotid artery. This is known as very advanced local disease (T4b). It might or might not have spread to nearby lymph nodes (Any N). It has not spread to distant organs (M0). |
|
IVC |
Any T Any N M1 |
The cancer is any size and may have grown into nearby soft tissues or structures (Any T) AND it might or might not have spread to nearby lymph nodes (Any N). It has spread to distant sites such as the lungs (M1). |
* The following additional categories are not described in the table above:
- TX: Main tumor cannot be assessed due to lack of information.
- T0: No evidence of a primary tumor.
- NX: Regional lymph nodes cannot be assessed due to lack of information.
p16 (HPV)-positive oropharynx cancer stages
AJCC stage |
Stage grouping |
p16 (HPV)-positive oropharynx cancer stage description* (2 cm = about ¾ inch; 4 cm = about 1½; 6 cm = about 2½ inches) |
I |
T0, T1 or T2 N0 or N1 M0 |
The cancer is no larger than 4 cm (T0 to T2) AND any of the following:
It has not spread to distant sites (M0). |
II |
T0, T1 or T2 N2 M0 |
The cancer is no larger than 4 cm (T0 to T2) AND it has spread to 1 or more lymph nodes on the opposite side of the primary cancer or both sides of the neck, and none are larger than 6 cm (N2). It has not spread to distant sites (M0). |
OR |
||
T3 or T4 N0 or N1 M0 |
The cancer is larger than 4 cm (T3) OR is growing into the epiglottis (the base of the tongue) (T3) OR is growing into the larynx (voice box), the tongue muscle, or bones such as the medial pterygoid plate, the hard palate, or the jaw (T4) AND any of the following:
It has not spread to distant sites (M0). |
|
III
|
T3 or T4 N2 M0 |
The cancer is larger than 4 cm (T3) OR is growing into the epiglottis (the base of the tongue) (T3) OR is growing into the larynx (voice box), the tongue muscle, or bones such as the medial pterygoid plate, the hard palate, or the jaw (T4) AND it has spread to 1 or more lymph nodes on the opposite side of the primary cancer or both sides of the neck, and none are larger than 6 cm (N2). It has not spread to distant sites (M0). |
IV |
Any T Any N M1 |
The cancer is any size and may have grown into nearby structures (Any T) AND it might or might not have spread to nearby lymph nodes (Any N). It has spread to distant sites such as the lungs or bones (M1). |
* The following additional categories are not described in the table above:
- TX: Main tumor cannot be assessed due to lack of information.
- T0: No evidence of a primary tumor.
- NX: Regional lymph nodes cannot be assessed due to lack of information.
Recurrent (relapsed) cancer
This is not an actual stage in the TNM system. Recurrent (relapsed) cancer means that the cancer has come back (recurred) after treatment. Recurrent oral cavity or oropharyngeal cancer may return in the mouth or throat (local recurrence), in nearby lymph nodes (regional recurrence), or in another part of the body, such as the lungs (distant recurrence).
Talk with your doctor if you have any questions about the stage of your cancer or how it affects your treatment.
- Written by
- References
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
American Joint Committee on Cancer. Lip and Oral Cavity. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017:79.
American Joint Committee on Cancer. HPV-Mediated (p16+) Oropharyngeal Cancer. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017:113.
American Joint Committee on Cancer. Oropharynx (p16-) and Hypopharynx. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017:123.
Last Revised: March 23, 2021
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.
More in Oral Cavity and Oropharyngeal Cancer
Help us end cancer as we know it, for everyone.
